InsidersTradesSigma
Explore the complete record of transactions filed by Murphy Nicole, Responsable des Opérations Pharmaceutiques et de la Technologie. Insider active across 1 companies, notably BIOGEN INC.. Aggregated, 3 disclosures have been recorded. The latest transaction was disclosed on 18 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Murphy Nicole serves as the Head of Pharm Ops and Tech at BIOGEN INC. In this role, she oversees operations related to the production and distribution of pharmaceutical products. Nicole is responsible for optimizing operational processes to ensure efficiency and regulatory compliance. Her expertise is essential in supporting innovation and product quality at Biogen.